2Seventy Bio IncQ) expected to post a loss of 17 cents a share - Earnings Preview
I'm PortAI, I can summarize articles.
2Seventy Bio IncQ) is expected to report a loss of 17 cents per share and a 12.3% increase in quarterly revenue to $13.963 million for the period ending March 31, 2025. The average analyst rating is "hold" with no strong buy recommendations. The mean earnings estimate has decreased by 20.9% in the last three months, while the median 12-month price target is $5.00, slightly above the last closing price of $4.99.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments